Patent ID: 7049337

Claim:
A compound exhibiting differential activity between dopamine receptor subtypes, said compound being an 2-aminotetralin or biosteric analog thereof containing a fused ring structure, one ring comprising an optionally ring substituted moiety or a pharmaceutically acceptable salt of said compound, wherein X is CH 2 , O, NH, or S, n is 0 or 1, and R is ethyl, butyl, or a C 5-20 hydrocarbon, each optionally substituted by one or more halo, nitro, amino, aminoalkyl, or cyano groups, or R is a halo-, nitro-, amino-, cyano- or aminoalkyl-substituted propyl group, R optionally containing one or more heteroatoms selected from the group consisting of O, N, and S, and optionally containing a keto, thio, ester, carbonate, urea, amide, or urethane group and where said optionally ring substituted moiety may contain one or two sites of ethylenic unsaturation.